Showing 2231-2240 of 4167 results for "".
- Candela Launches Vbeam Primahttps://modernaesthetics.com/news/canola-launches-vbeam-prima/2472064/Recently FDA-cleared, the Vbeam Prima from Candela offers two wavelengths to effectively treat a broad range of skin conditions including rosacea, spider veins, wrinkles, acne and more. Vbeam Prima’s re-designed 595 nm PD
- First-ever Data on Vaginal Regeneration for ThermiVahttps://modernaesthetics.com/news/first-ever-data-on-vaginal-regeneration-for-thermiva/2472081/Thermi’s ThermiVa® device has been shown to deliver significant improvements in common vaginal disorders and improve sexual satisfaction, according to a study published in Dermatologic Surgery. Since it was cleared by the FDA in 2013, ThermiVa has been used in more t
- Jacob Chacko, MD Joins Bonti's Board of Directorshttps://modernaesthetics.com/news/jacob-chackomd-joins-bontis-board-of-directors/2472135/Jacob Chacko, MD has joined Bonti’s Board of Directors. Dr. Chacko has served as the Chief Financial Officer of Ignyta, Inc. since May 2014. At Ignyta, he leads multiple functions, including Finance, Accounting, Investor Relations, Comm
- Juvéderm Vollure XC FDA Approved for Correction of Facial Wrinkles and Foldshttps://modernaesthetics.com/news/juvderm-vollure-xc-fda-approved-for-correction-of-facial-wrinkles-and-folds/2472255/The FDA has approved Allergan plc's Juvéderm Vollure XC for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21. In the US pivotal clinical trial, a majority (59 percent) of subjects saw improvement in moderate to severe na
- Merz Aesthetics Secures FDA Approval for RADIESSE in Décolleté Treatmenthttps://modernaesthetics.com/news/merz-aesthetics-secures-fda-approval-for-radiesse-in-decollete-treatment/2486550/Merz Aesthetics has received US Food and Drug Administration (FDA) approval for RADIESSE® (calcium hydroxylapatite [CaHA]) for the treatment of moderate to severe wrinkles in the décolleté in adults aged 22 years and older, according to a company announcement. The decision expands the
- Female Authorship Rises in Facial Plastic Surgery Literature, But Gaps Remainhttps://modernaesthetics.com/news/female-authorship-rises-in-facial-plastic-surgery-literature-but-gaps-remain/2486534/A cross-sectional bibliometric analysis published in Facial Plastic Surgery & Aesthetic Medicine examined trends in female authorship across facial plastic surgery literature from 2007 to 2022. The study evaluated 6,921 original research articles from 3 journals, assessing authorship
- Female Authorship Rises in Facial Plastic Surgery Literature, But Gaps Remainhttps://modernaesthetics.com/news/female-authorship-rises-in-facial-plastic-surgery-literature-but-gaps-remain/2486533/A cross-sectional bibliometric analysis published in Facial Plastic Surgery & Aesthetic Medicine examined trends in female authorship across facial plastic surgery literature from 2007 to 2022. The study evaluated 6,921 original research articles from 3 journals, assessing authorship
- New Data Highlight How Ultrasound Imaging May Improve Safety in High-Risk Filler Injectionshttps://modernaesthetics.com/news/new-data-highlights-how-ultrasound-imaging-may-improve-safety-in-high-risk-filler-injections/2486532/The use of dermal fillers continues to expand across aesthetic practice, accompanied by ongoing concerns regarding vascular adverse events (VAEs), including tissue necrosis and vision loss. In a recent publication in Aesthetic Plastic Surgery, investigators evaluated the role of high-res
- Systematic Review Examines Vaginal Laser and Radiofrequency for Stress Urinary Incontinencehttps://modernaesthetics.com/news/systematic-review-examines-vaginal-laser-and-radiofrequency-for-stress-urinary-incontinence/2486518/In a systematic review and meta-analysis published in International Urogynecology Journal, investigators reported that energy-based devices may offer modest short-term symptom improvement for women with stress urinary incontinence compared with sham treatment. David Lukanović, Gee
- GPX4 Modulator Shows Early Promise in First-in-Human Studyhttps://modernaesthetics.com/news/gpx4-modulator-shows-early-promise-in-first-in-human-study/2486474/A novel topical therapy targeting cellular senescence showed early biologic activity across multiple dermatologic conditions in a Phase 1 clinical trial, according to data presented by Frederick Beddingfield III, MD, PhD, FAAD, at the Dermatology Innovation Forum during the American Academy of De